EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Anti-SARS-CoV-2 antibody kinetics up to 6 months of follow-up: Result from a nation-wide population-based, age stratified sero-epidemiological prospective cohort study in India

Puneet Misra iD, Arvind Kumar Singh, Baijayantimala Mishra, Bijayini Behera iD, Binod Kumar Patro iD, Guruprasad R Medigeshi, Hari Shanker Joshi iD, Mohammad Ahmad, Pradeep Kumar Chaturvedi, Palanivel Chinnakali, Partha Haldar, Mohan Bairwa und 14 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0287807 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS ONE, 2023. Verfasst von Puneet Misra und 25 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, World Health Organization Centre for Health Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Repeated serological testing tells about the change in the overall infection in a community. This study aimed to evaluate changes in antibody prevalence and kinetics in a closed cohort over six months in different sub-populations in India. The study included 10,000 participants from rural and urban areas in five states and measured SARS-CoV-2 antibodies in serum in three follow-up rounds. The overall seroprevalence increased from 73.9% in round one to 90.7% in round two and 92.9% in round three. Among seropositive rural participants in round one, 98.2% remained positive in round two, and this percentage remained stable in urban and tribal areas in round three. The results showed high antibody prevalence that increased over time and was not different based on area, age group, or sex. Vaccinated individuals had higher antibody prevalence, and nearly all participants had antibody positivity for up to six months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansProspective StudiesSeroepidemiologic StudiesSARS-CoV-2Antibodies, ViralIndia

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Community and Family Medicine, All India Institute of Medical Sciences, Bhubaneshwar, Odisha, India.
  • Department Microbiology, All India Institute of Medical Sciences, Bhubaneshwar, Odisha, India.
  • Translational Health Science and Technology Institute, Faridabad, India.
  • Department of Community and Family Medicine, All India Institute of Medical Sciences, Gorakhpur, India.
  • World Health Organization, WHO Country Office, New Delhi, India.

ORCID-Profile: Puneet Misra, Bijayini Behera, Binod Kumar Patro, Hari Shanker Joshi, Suprakash Mandal

Förderung

  • World Health Organization
  • World Health Organization Centre for Health Development

Zitieren

APA

Misra, P., Singh, A. K., Mishra, B., Behera, B., Patro, B. K., Medigeshi, G. R., Joshi, H. S., Ahmad, M., Chaturvedi, P. K., Chinnakali, P., Haldar, P., Bairwa, M., Kharya, P., Dhodapkar, R., Rath, R., Guleria, R., Rai, S. K., Kar, S. S., Kant, S., …, & Hada, V. (2023). Anti-SARS-CoV-2 antibody kinetics up to 6 months of follow-up: Result from a nation-wide population-based, age stratified sero-epidemiological prospective cohort study in India. PLOS ONE. https://doi.org/10.1371/journal.pone.0287807

Vancouver

Misra P, Singh AK, Mishra B, Behera B, Patro BK, Medigeshi GR, et al. Anti-SARS-CoV-2 antibody kinetics up to 6 months of follow-up: Result from a nation-wide population-based, age stratified sero-epidemiological prospective cohort study in India. PLOS ONE. 2023. doi:10.1371/journal.pone.0287807

BibTeX
@article{Misra2023,
  author = {Misra, Puneet and Singh, Arvind Kumar and Mishra, Baijayantimala and Behera, Bijayini and Patro, Binod Kumar and Medigeshi, Guruprasad R and Joshi, Hari Shanker and Ahmad, Mohammad and Chaturvedi, Pradeep Kumar and Chinnakali, Palanivel and Haldar, Partha and Bairwa, Mohan and Kharya, Pradeep and Dhodapkar, Rahul and Rath, Ramashankar and Guleria, Randeep and Rai, Sanjay Kumar and Kar, Sitanshu Sekhar and Kant, Shashi and Sarkar, Sonali and Baidya, Subrata and Meena, Suneeta and Mandal, Suprakash and Kishore, Surekha and Majumder, Tapan and Hada, Vivek},
  title = {Anti-SARS-CoV-2 antibody kinetics up to 6 months of follow-up: Result from a nation-wide population-based, age stratified sero-epidemiological prospective cohort study in India},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0287807}
}
Kostenlos starten →